KITE
Kite Pharma Inc
Clinical-stage biopharmaceutical company developing cancer immunotherapies
CUSIP: 49803L109HealthcareUS1 holder
Total Value
$136.01M
Total Shares
2.21M
Net Share Change
-265.4K
Activity
1 selling
Investor
Value
Shares
Weight
Change
Viking Global Investors
$136.01M2.21M shares
TRIM-265.4K(-10.7%)